Home › Funds › EVOLVE PRIVATE WEALTH, LLC › UTHR

EVOLVE PRIVATE WEALTH, LLC position in UTHR

UNITED THERAPEUTICS CORP DEL · Health Care

EVOLVE PRIVATE WEALTH, LLC reported holding 12,502 shares of UTHR (UNITED THERAPEUTICS CORP DEL) in its Q3 2026 13F filing — a position valued at US$6.8M, representing 0.32% of its reported portfolio and ranking #50 among its reported holdings. EVOLVE PRIVATE WEALTH, LLC has disclosed UTHR holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)12.50K sh
Reported value held$6.77M
Portfolio Weight0.32%
First reportedQ4 2025
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How EVOLVE PRIVATE WEALTH, LLC's UTHR position evolved

EVOLVE PRIVATE WEALTH, LLC first disclosed a stake in UTHR in Q4 2025 at 14,020 shares (US$6.8M). The position peaked in Q1 2026 at 12,913 shares, worth US$7.7M. Across 4 filings, EVOLVE PRIVATE WEALTH, LLC increased the stake 0 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 12,502 shares valued at US$6.8M — a reduction of -233 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q4 2025 14.02K $6.83M New
Q1 2026 12.91K $7.66M Reduce
Q2 2026 12.73K $6.90M Reduce
Q3 2026 12.50K $6.77M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About UTHR and 13F data

UTHR (UNITED THERAPEUTICS CORP DEL) is a Health Care company. 39 other funds we track also report a position in UTHR — the largest reported positions include Avoro Capital Advisors LLC (US$1.51B), Renaissance Technologies (US$908.2M), ASSETMARK, INC (US$325.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding UTHR

All UTHR fund holders →

FAQ

How long has EVOLVE PRIVATE WEALTH, LLC held UTHR?

EVOLVE PRIVATE WEALTH, LLC has disclosed UTHR holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is EVOLVE PRIVATE WEALTH, LLC's current position in UTHR?

As of Q3 2026, EVOLVE PRIVATE WEALTH, LLC holds 12.50K shares of UTHR (UNITED THERAPEUTICS CORP DEL), valued at $6.77M, representing 0.32% of its reported portfolio and ranking #50.

Has EVOLVE PRIVATE WEALTH, LLC been buying or selling UTHR?

In the latest 13F filing (Q3 2026), EVOLVE PRIVATE WEALTH, LLC reduced its position in UTHR. The position peaked in Q1 2026 at 12.91K shares.

Which other funds hold UTHR?

Other major institutional holders of UTHR include Avoro Capital Advisors LLC, Renaissance Technologies, ASSETMARK, INC, among 39 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.